SCHEMBL9890594

SCHEMBL9890594

c1ccc(-n2c3ccc(-n4c5ccccc5c5ccccc54)cc3c3c4c(ccc32)sc2ccc(-n3c5ccccc5c5ccccc53)cc24)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.50
KDM4E B2RXH2 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
HSD17B10 Q99714 2/20 0.36
KMT2A Q03164 4/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
BRCA1 P38398 1/20 0.33
GAA P10253 1/20 0.33
PTPN1 P18031 2/20 0.32
PDE1B Q01064 1/20 0.32
PDE3A Q14432 1/20 0.32
PDE11A Q9HCR9 1/20 0.32
GPR3 P46089 1/20 0.32
HDAC4 P56524 1/20 0.32
MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18119116 0.96 ATM (0.49) ATMKDM4EL3MBTL1JAK2JAK3
SCHEMBL15759625 0.92 ATM (0.47) ATMKDM4EL3MBTL1JAK2JAK3
SCHEMBL18119098 0.90 ATM (0.45) ATMKDM4EL3MBTL1JAK2JAK3
SCHEMBL18119563 0.90 ATM (0.43) ATMKDM4EL3MBTL1JAK2JAK3
SCHEMBL9890611 0.90 KDM4E (0.47) ATMKDM4EL3MBTL1HSD17B10KMT2A
SCHEMBL18119147 0.90 L3MBTL1 (0.41) ATMKDM4EL3MBTL1JAK2JAK3
SCHEMBL18119092 0.88 L3MBTL1 (0.41) ATMKDM4EL3MBTL1JAK2JAK3
SCHEMBL18119089 0.88 L3MBTL1 (0.41) ATMKDM4EL3MBTL1JAK2JAK3
SCHEMBL26809691 0.88 ATM (0.49) ATMKDM4EL3MBTL1JAK2JAK3
SCHEMBL17245434 0.87 ATM (0.47) ATMKDM4EL3MBTL1JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 ATM 3103/4885KDM4E 990/4885L3MBTL1 709/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 ATM 3103/4885KDM4E 990/4885L3MBTL1 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.